Navigation Links
Amicus Therapeutics Announces Transition of John F. Crowley from Chairman and Chief Executive Officer to Executive Chairman
Date:4/18/2011

CRANBURY, N.J., April 18, 2011 /PRNewswire/ -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley will transition from Chairman and Chief Executive Officer to Executive Chairman in order to devote more time to interests related to public policy, civic service, and philanthropic endeavors. In his role as Executive Chairman, Mr. Crowley will continue to perform his duties as Chairman of the Board of Directors and will advise the current Amicus management team on corporate strategy and the further advancement of the Company's product development pipeline.

"Amicus is in a strong strategic and financial position today as a result of its Phase 3 program in Fabry Disease, a global partnership with GSK Rare Diseases, an exciting pipeline of additional programs, and a dedicated team of employees," said Mr. Crowley. "The management team at Amicus has driven this success to date and the Company is exceptionally well-positioned to advance its vision as a leader in the development of new therapies for rare diseases. In my new role, I look forward to working with the team toward this goal."

"John is an extraordinary leader for Amicus and a champion for the rare disease community," said Donald J. Hayden, Jr., Lead Independent Director of Amicus. "He has developed an outstanding management team at Amicus and we look forward to continuing to work closely with John during his term as Executive Chairman. On behalf of the Board of Directors, I wish John great success."

Matthew R. Patterson, President and Chief Operating Officer of Amicus, has been appointed Acting Chief Executive Officer in addition to his duties as President, effective immediately. The Amicus Board of Directors intends to shortly initiate a search for a full-time Chief Executive Officer and will include Mr. Patterson as a candidate for the position.

"Matt is a proven leader at Amicus
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for Pompe Disease
2. Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigal™ Co-administered with Enzyme Replacement Therapy
3. Amicus Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011
4. Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinsons Disease
5. Amicus Therapeutics Announces Third Quarter 2010 Financial Results
6. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
7. Amicus Therapeutics to Host Conference Call and Webcast to Discuss Exclusive Worldwide Agreement with GSK to Develop and Commercialize Amigal™ for Fabry Disease
8. Amicus Therapeutics to Host Its Second Quarter 2010 Financial Results Conference Call and Webcast on August 5, 2010
9. Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
10. Alzheimers Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology
11. Fenwal Receives FDA Clearance for Amicus(R) Separator With Wireless Connectivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... focused on the development and commercialization of novel bile ... the pricing of an underwritten public offering of 1,730,000 ... price of $33.01 per share.  In addition, Intercept has ... to an additional 259,500 shares of common stock. ...
(Date:6/18/2013)... PROSPECT, Ill. , June 18, 2013 /PRNewswire-iReach/ ... of its new X3130 Appliance Inlet Module. The ... circuit breaker , combines a C14 appliance inlet ... one compact package.  This three-in-one device allows design ... their designs - cutting installation time by 66 ...
(Date:6/18/2013)... ROCKY HILL, Conn. , June 18, 2013 ... many past clients of Alliance Seating and Mobility, ... now unable to access timely repair. This appears ... and a dramatic reduction of field service employees.  ... Unfortunately a great many of these clients ...
Breaking Medicine Technology:Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Three-in-One X3130 Appliance Inlet Module 2
... Mylan Inc. (Nasdaq: MYL ) today ... final approval from the U.S. Food and Drug Administration ... Pantoprazole Sodium Delayed-release (DR) Tablets USP, 20 mg (base) ... Protonix® DR Tablets, a treatment for the irritation of ...
... ICAP Ocean Tomo , the ... the world,s premier patent auction firm, announces the sale ... Consisting of seven issued patents and seven related applications ... to companies involved in areas such as lighting, x-ray, ...
Cached Medicine Technology:Cutting Edge Nanotech Patents for Displays, Lighting, X-ray, Medical Imaging, and Diagnostics Available for Sale by ICAP Ocean Tomo 2
(Date:6/19/2013)... FL (PRWEB) June 19, 2013 Ultimate ... Children's Telethon, an 11.5-hour broadcast on WFLA News Channel ... has collected more than $84 million for All Children's ... 2013, event, themed "30 Years of Miracles," marked the ... hour, 18 UMA employees worked the phones during the ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Next ... a premier kids entertainment media organization, and ... games company, will be introducing the Games for ... The 3D game is geared toward students in ... and active lifestyles by rewarding positive choices. The ...
(Date:6/19/2013)... Riverside, CA (PRWEB) June 19, 2013 Recently, ... Arc of Riverside County held their third in a series ... the National Wall of Respect and helped place the mosaic tiles ... Erin Maxwell and her parents, Cathy and Greg Maxwell. , ... result of an idea that took root over three years ago ...
(Date:6/19/2013)... 2013 Maui'd Forever , Hawaii's ... being an effective and cost effective way to provide ... partnered up with Tom Barefoot’s Tours providing an activity ... of Hawaii’s activities. , They have just released a ... the lowest prices on their Hawaii activities. , ...
(Date:6/19/2013)... June 19, 2013 According to Transparency ... Market Share, Trends, Analysis and Forecast, 2011 – 2017,” ... billion in the year 2011 and is expected to ... CAGR of 9.7% from 2011 to 2017. Flexible endoscopes ... contributing about USD 2,201 million for the year 2011. ...
Breaking Medicine News(10 mins):Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 4Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 5Health News:Arc Creates Huge Mosaic Mural to Highlight the Need for Greater Respect of People with Disabilities 2Health News:Maui'd Forever Pleased to Offer Price Guarantee on Hawaii Activities 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 3
... The Simmons firm, a leading national law firm in the ... second Miles for Meso 5K run/walk on Sunday, October 11, ... at www.milesformeso.org . , The Simmons ... 26 in Alton, Ill. Nearly 500 runners and walkers registered, ...
... ... the return of PRE-PEN® penicillin allergy skin testing products to the market. PRE-PEN® received ... with AllerQuest to market and distribute PRE-PEN®. , ... Round Rock, TX (PRWEB) September 30, 2009 -- ALK-Abelló, ...
... play a role, expert contends, , WEDNESDAY, Sept. 30 (HealthDay ... of surgery, not just the rate of those complications, determines ... , The study, which included more than 84,000 people who ... difference in surgical deaths between hospitals with the lowest rate ...
... , CARLSBAD, Calif., Sept. 30 Jenny Craig, Inc., one ... actress and comedian Nicole Sullivan as the newest Jenny Craig ... gave birth to her second child in August 2009, is ... 35 pounds. , (Photo: http://www.newscom.com/cgi-bin/prnh/20090930/NY84610 ...
... 30 Healthcare Realty Trust Incorporated (NYSE: HR ) ... credit facility, which replaces the previous $400 million facility. ... 2012. The facility is priced at 2.80% over LIBOR, ... terms and conditions customary for loans of this nature. ...
... among those with OCD or Tourette syndrome ... have suggested that strep throat may cause or trigger ... has found no evidence of a link. , ... much rarer neuropsychiatric disorders," Dr. Anette Schrag of the ...
Cached Medicine News:Health News:Simmons Law Firm Presents Second 'Miles for Meso' Walk/Run Fundraiser for Mesothelioma Research 2Health News:FDA Approves PRE-PEN Penicillin Allergy Test 2Health News:Surgical Deaths Linked to Handling of Complications 2Health News:Surgical Deaths Linked to Handling of Complications 3Health News:Nicole Sullivan Joins Jenny Craig to Reclaim Her Pre-Baby Body 2Health News:Healthcare Realty Trust Announces New $550 Million Unsecured Revolving Credit Facility 2Health News:Study Debunks Link Between Strep and Brain Disorders 2
Immersion oils may crystallize on storage. Can be redissolved on heating to 50ºC (1-2 hours)...
Immersion oil for microscopy...
... Type DF is the highest resolution ... microscopy and it also exhibits extremely ... FF has virtually zero fluorescence and ... oil of choice when low levels ...
... - the ones to compare with, the ones ... in the development and standardization of immersion oil ... , When the FDA set general purpose reagent ... in the 1970's, Cargille Immersion Oils were already ...
Medicine Products: